For Inventors
For Investors
For Corporates
Portfolio
About
Portfolio
About
Investor login
Investor login
Close Cookie Popup
Cookie Preferences
By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts as outlined in our
cookie policy
.
Strictly Necessary (Always Active)
Cookies required to enable basic website functionality.
Analytics
Cookies helping us understand how this website performs, how visitors interact with the site, and whether there may be technical issues.
Marketing
Cookies used to deliver advertising that is more relevant to you and your interests.
Personalization
Cookies allowing the website to remember choices you make (such as your user name, language, or the region you are in).
Customize
Save
Decline All
Accept All
News
NLC completes first close of €100 million health impact fund
https://nlc-health.webflow.io/news/nlc-completes-first-close-of-eu100m-health-impact-fund
By
Nanna Liebregt
May 2024
•
5 min read
Click to copy this page's URL
Copied to clipboard!
By
Nanna Liebregt
May 2024
•
5 min read
Click to copy this page's URL
Copied to clipboard!
Read article on external website
Share this post
Click to copy this page's URL
Copied to clipboard!
News
Insights
Jul 2024
Insights
Nina Rijnders: Impact investing for philanthropic fund (In Dutch)
Insights
Nina Rijnders: Impact investing for philanthropic fund (In Dutch)
Jul 2024
News
SERDA Therapeutics Announces Completion of First Phase 1 Clinical Study of SN514
News
SERDA Therapeutics Announces Completion of First Phase 1 Clinical Study of SN514
Jun 2024
Venture launches
Introducing Exolvo: NLC Health Ventures launches new early-stage drug delivery company
Venture launches
Introducing Exolvo: NLC Health Ventures launches new early-stage drug delivery company
Jun 2024
News
Dutch health insurer VGZ invests €6 million in NLC Health Ventures
News
Dutch health insurer VGZ invests €6 million in NLC Health Ventures
May 2024
News
NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted
News
NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted
May 2024
News
NLC venture Altach secures €1.2 million investment to transform treatments for cartilage injuries
News
NLC venture Altach secures €1.2 million investment to transform treatments for cartilage injuries
Apr 2024
News
AI Healthtech start-up MindAffect raises €1.1 million to transform hearing diagnostics
News
AI Healthtech start-up MindAffect raises €1.1 million to transform hearing diagnostics
Apr 2024
News
IPD secures funding of €2.1 million to initiate its first-in-human trials for prosthetic joint infections
News
IPD secures funding of €2.1 million to initiate its first-in-human trials for prosthetic joint infections
Feb 2024
Venture launches
Introducing Aerion Bioscience: A new era of cancer screening
Venture launches
Introducing Aerion Bioscience: A new era of cancer screening
Jan 2024
News
CUIP and NLC Health Ventures signed a MoU to bring cutting-edge innovations to life
News
CUIP and NLC Health Ventures signed a MoU to bring cutting-edge innovations to life
Dec 2023
News
POROUS wins innovation award
News
POROUS wins innovation award
Dec 2023
News
Ansana secures a €850,000 investment
News
Ansana secures a €850,000 investment
Dec 2023
Venture launches
Introducing LiftYa: Stability with motion
Venture launches
Introducing LiftYa: Stability with motion
Nov 2023
Venture launches
Introducing StarTric: Transcatheter tricuspid heart valve repair
Venture launches
Introducing StarTric: Transcatheter tricuspid heart valve repair
Nov 2023
Venture launches
Introducing Amotio: Revolutionising orthopaedic revision surgery: An innovative approach to major joint implant revisions
Venture launches
Introducing Amotio: Revolutionising orthopaedic revision surgery: An innovative approach to major joint implant revisions
Nov 2023
News
NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted.
News
NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted.
Nov 2023
Venture launches
Introducing our newest venture ChARM: Empowering low-resource healthcare professionals around the world
Venture launches
Introducing our newest venture ChARM: Empowering low-resource healthcare professionals around the world
Oct 2023
Venture launches
Introducing our newest venture: Asclepius
Venture launches
Introducing our newest venture: Asclepius
Oct 2023
Venture launches
Introducing our venture Nilocas: A cardiac device for the detection of coronary artery disease
Venture launches
Introducing our venture Nilocas: A cardiac device for the detection of coronary artery disease
Oct 2023
News
Porous nominated for the Innovation Award Berlin Brandenburg
News
Porous nominated for the Innovation Award Berlin Brandenburg